Cizzle Bio and the CIZ1B Biomarker Blood Test for Lung Cancer were featured in GenomeWeb. The article examines the science behind CIZ1B and peer-reviewed results showing 94% sensitivity and 97% negative predictive value for stage I and II lung cancer.
@cizzlebio.com